These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1684016)

  • 61. Molecular genetics of acute leukaemia.
    Sawyers CL
    Lancet; 1997 Jan; 349(9046):196-200. PubMed ID: 9111557
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Arsenic trioxide may improve the prognosis of APL with ider(17)(q10): report of a rare adult case of acute promyelocytic leukemia with ider(17)(q10)t(15;17) showing poor response to all-trans retinoic acid.
    Tong H; Li K; Mei C; Wang H; Chen Z; Jin J
    Ann Hematol; 2011 Dec; 90(12):1493-4. PubMed ID: 21431323
    [No Abstract]   [Full Text] [Related]  

  • 63. All-trans retinoic acid in acute promyelocytic leukemia in late pregnancy.
    Stentoft J; Nielsen JL; Hvidman LE
    Leukemia; 1994 Sep; 8(9):1585-8. PubMed ID: 8090035
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Quality of life with treated acute promyelocytic leukaemia.
    Rahman A
    Lancet Oncol; 2014 Nov; 15(12):e533. PubMed ID: 25602107
    [No Abstract]   [Full Text] [Related]  

  • 65. Therapeutic efficacy of interferon alfa-2a and 13-cis-retinoic acid in recurrent angiosarcoma of the head.
    Spieth K; Gille J; Kaufmann R
    Arch Dermatol; 1999 Sep; 135(9):1035-7. PubMed ID: 10490107
    [No Abstract]   [Full Text] [Related]  

  • 66. Interferon alpha and all-trans retinoic acid-induced in vivo differentiation in a patient with nonlymphoblastic leukemia (FAB:M4).
    Itoh K; Ogura H; Murakami H
    Am J Hematol; 1994 May; 46(1):61-2. PubMed ID: 8184881
    [No Abstract]   [Full Text] [Related]  

  • 67. Transcriptional drug repositioning and cheminformatics approach for differentiation therapy of leukaemia cells.
    KalantarMotamedi Y; Ejeian F; Sabouhi F; Bahmani L; Nejati AS; Bhagwat AM; Ahadi AM; Tafreshi AP; Nasr-Esfahani MH; Bender A
    Sci Rep; 2021 Jun; 11(1):12537. PubMed ID: 34131166
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Metabolic subtype reveals potential therapeutic vulnerability in acute promyelocytic leukaemia.
    Sung JY; Yun W; Kim HY; Kim HJ; Choi JR; Kim SH; Jung CW; Lee ST
    Clin Transl Med; 2022 Jul; 12(7):e964. PubMed ID: 35808815
    [No Abstract]   [Full Text] [Related]  

  • 69. Central nervous system relapse of acute promyelocytic leukaemia in a patient with cerebral haemorrhage at diagnosis.
    Macheta MP; Shun JK; Yin JA
    Br J Haematol; 2001 Sep; 114(4):954-5. PubMed ID: 11564092
    [No Abstract]   [Full Text] [Related]  

  • 70. Retinoid resistance.
    Warrell RP
    Lancet; 1993 Jan; 341(8837):126. PubMed ID: 8093401
    [No Abstract]   [Full Text] [Related]  

  • 71. Modulation of all-trans retinoid acid pharmacokinetics in acute promyelocytic leukaemia by prolonged interferon-alpha therapy.
    Lazzarino M; Corso A; Regazzi MB; Iacona I; Bernasconi C
    Br J Haematol; 1995 Aug; 90(4):928-30. PubMed ID: 7669674
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Primary treatment of acute promyelocytic leukemia using all-trans-retinoic acid].
    Leeksma OC; van Oers MH; van der Schoot CE; Goudsmit R; von dem Borne AE
    Ned Tijdschr Geneeskd; 1993 Apr; 137(16):821-5. PubMed ID: 8487886
    [TBL] [Abstract][Full Text] [Related]  

  • 73. All trans retinoic acid in acute promyelocytic leukemia.
    Degos L; Castaigne S; Fenaux P; Daniel MT; Dombret H; Chomienne C
    Nouv Rev Fr Hematol (1978); 1991; 33(2):183-5. PubMed ID: 1766850
    [No Abstract]   [Full Text] [Related]  

  • 74. All-trans retinoic acid in myelogenous leukaemia.
    Gallagher RE; Wiernik PH
    Lancet; 1991 Dec 21-28; 338(8782-8783):1603. PubMed ID: 1684016
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.